Cervical Squamous Cell Carcinoma — Trials

Cervical Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 44%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 16.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02042885	A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer	terminated	Phase 1 / Phase 2	79	Otsuka Novel Products GmbHINDUSTRY	1	Oct 20, 2015	clinicaltrials

Data updated 22 days agoSource updated Oct 20, 2015source: clinicaltrials